Journal of the Neurological Sciences
Volume 213, Issue 1 , Pages 67-76, 15 September 2003

A case of lymphomatoid granulomatosis/angiocentric immunoproliferative lesion with long clinical course and diffuse brain involvement

  • Toshiki Mizuno

      Affiliations

    • Department of Neurology and Gerontology, Institute for Neurological Diseases and Geriatrics, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-75-251-5793; fax: +81-75-211-8645.
  • ,
  • Yoshiaki Takanashi

      Affiliations

    • Department of Neurology and Gerontology, Institute for Neurological Diseases and Geriatrics, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan
  • ,
  • Hideki Onodera

      Affiliations

    • Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan
  • ,
  • Masako Shigeta

      Affiliations

    • Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan
  • ,
  • Naoki Tanaka

      Affiliations

    • Department of Neurology and Gerontology, Institute for Neurological Diseases and Geriatrics, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan
  • ,
  • Hiromichi Yuya

      Affiliations

    • Department of Neurology and Gerontology, Institute for Neurological Diseases and Geriatrics, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan
  • ,
  • Masanori Kitaichi

      Affiliations

    • Laboratory of Anatomic Pathology, Kyoto University Hospital, Kyoto 606-8507, Japan
  • ,
  • Kenji Nakajima

      Affiliations

    • Department of Neurology and Gerontology, Institute for Neurological Diseases and Geriatrics, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan

Received 28 August 2002; received in revised form 11 April 2003; accepted 14 April 2003.

Abstract 

Lymphomatoid granulomatosis (LYG)/angiocentric immunoproliferative lesions (AIL) consist of angiocentric and angiodestructive lymphoreticular proliferation predominantly involving the lungs and other extranodal sites, such as the central nervous system (CNS). This clinical entity is considered as a B cell process related to Epstein–Barr virus (EBV) infection and EBV positive diffuse large B-cell lymphoma. The CNS is involved in 20% of cases of LYG, but initial involvement is rare. In cases without pulmonary symptoms, diagnosis may be difficult. We report a rare case involving initial progression of CNS symptoms followed by a pulmonary abnormality.

A 14-year-old girl suffered from high fever, ataxic gait and paraparesis. MRI revealed diffuse T2 high signals with multiple gadolinium enhancements in the cerebellum, brain stem and cerebral white matter. Her symptoms briefly improved after steroid therapy, but ataxia gradually progressed. Dyspnea due to pulmonary interstitial involvement appeared when she was 18 years old. Steroid therapy proved effective for respiratory symptoms. At 20 years old she suffered from disseminated intravascular coagulopathy (DIC) and hemophagocytic syndrome (HPS) with respiratory symptoms and repeated seizures. Her symptoms improved after the administration of cyclophosphamide. Mild hemiparesis and gait disturbance appeared when she was 22 years old. MRI revealed new lesions at the basal ganglia and subcortical white matter, brain atrophy and diffuse T2 high intensity of cerebral white matter. Cyclophosphamide was effective and there has been no recurrence of symptoms in the last 5 years. We reviewed the non-tumorous LYG/AIL involving the CNS, and discussed the clinical features, MRI imaging and diagnosis of the LYG/AIL.

Keywords:  Lymphomatoid granulomatosis, Angiocentric immunoproliferative lesions, Central nervous system, MRI, Gadolinium enhancement

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-510X(03)00127-8

doi:10.1016/S0022-510X(03)00127-8

Journal of the Neurological Sciences
Volume 213, Issue 1 , Pages 67-76, 15 September 2003